Hancock Jaffe Laboratories (HJLI) Financial Analysis & Valuation | Quarter Chart
Hancock Jaffe Laboratories (HJLI)
HJLIPrice: $10.38
Fair Value: 🔒
🔒score
Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. The company is headquartered in Irvine... more
Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissu... more
Description
Shares
| Market Cap | $98.32M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Robert A. Berman |
| IPO Date | 2018-05-31 | CAGR | — |
| Employees | 19 | Website | www.hancockjaffe.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
HJLI chart loading...
Fundamentals
Technicals
| Enterprise Value | $4.79M | P/E Ratio | — |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | — | P/B Ratio | 0.31 |
| P/CF Ratio | -0.49 | P/FCF Ratio | -0.01 |
| EPS | — | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | — | Gross Margin | — |
| Operating Margin | — | Profit Margin | — |
| ROE | -0.66% | ROA | -0.72% |
| ROCE | -0.84% | Current Ratio | 11.89 |
| Quick Ratio | 11.89 | Cash Ratio | 1.21 |
| Debt/Equity | 0.03 | Interest Coverage | — |
| Altman Z Score | 14.31 | Piotroski Score | 3 |